SHZ · 002589.SZ
Realcan Pharmaceutical Group Co., Ltd.
CN¥2.86+CN¥0.11 (+4.0%)
Realcan Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.02% below the high.
Loading market information…
SHH · 605186.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai General Healthy Information and Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai General Healthy Information and Technology Co., Ltd.’s forward annual dividend is CN¥0.10 per share, paid annual. The forward yield is 0.43% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shanghai General Healthy Information and Technology Co., Ltd.’s next earnings report is currently expected on Oct 31, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai General Healthy Information and Technology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai General Healthy Information and Technology Co., Ltd. (SGHIT) delivers a range of advanced solutions to the healthcare sector in China. These encompass automated pharmaceutical logistics, cutting-edge information technology, and intelligent, mobile medical applications. Its core product portfolio features the "Smart Pharmacy Project," an integrated hardware and software system designed for intelligent medication management. Another key offering is the "Intelligent Static Distribution Center Project," a sophisticated system for the configuration and oversight of intravenous medications. Additionally, the "Intelligent Drug Consumables Management Project" provides specialized oversight for various pharmaceutical supplies, including controlled substances and high-value medical items. Established in 2014, SGHIT operates from its headquarters in Shanghai, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2024 |
|---|
| Aug 30, 2024 |
| CN¥0.18 |
| CN¥109.89M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥2.86+CN¥0.11 (+4.0%)
Realcan Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.02% below the high.
CN¥12.56+CN¥0.29 (+2.36%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
CN¥35.11+CN¥2.16 (+6.56%)
CareRay Digital Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.9% below the high.
CN¥27.30+CN¥0.64 (+2.4%)
Beijing Succeeder Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
CN¥12.70+CN¥0.43 (+3.5%)
Guangdong Transtek Medical Electronics Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
CN¥5.35+CN¥0.07 (+1.33%)
Shanghai Kehua Bio-engineering Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.05% below the high.
CN¥18.23+CN¥0.09 (+0.5%)
Allgens Medical Technology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.13% below the high.
CN¥15.63+CN¥0.41 (+2.69%)
Jianzhijia Pharmaceutical Chain Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.91% below the high.
